| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 150, 1037-1047, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
E van Garderen, M de Wit, WF Voorhout, GR Rutteman, JA Mol, H Nederbragt and W Misdorp
Department of Pathology, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
The role of progestins in the pathogenesis of breast cancer in women remains controversial. To advance this discussion, we report the demonstration and localization of progestin-induced biosynthesis of growth hormone (GH) in canine mammary gland tissue. Nontumorous mammary tissues and tumors, both benign and malignant, were obtained from private household dogs. Immunoreactive GH was localized in mammary epithelial cells and correlated with the presence of GH mRNA. Local synthesis of GH was also proven immunoelectron microscopically by demonstrating GH-containing secretory granules. Cellular GH production in nontumorous tissues was more extensive during the progesterone- dominated luteal phase of the ovarian cycle or during exposure to synthetic progestins than during anestrus. GH was also associated with areas of hyperplastic mammary epithelium, which may indicate that locally produced GH enhances proliferation, acting in an autocrine and/or paracrine manner. In 41 of 44 tumors, GH was present. Of 3 GH- negative tumor samples, 2 were from progestin-depleted, castrated bitches. In nonmalignant mammary tissues, GH production is stimulated by progesterone and synthetic progestins interacting with progesterone receptors. In some progesterone-receptor-negative malignant tumors, GH expression was found, indicating loss of this control. Progestin- induced GH probably participates in the cyclic development of the mammary gland but may promote mammary tumorigenesis by stimulating proliferation of susceptible, and sometimes transformed, mammary epithelial cells.
This article has been cited by other articles:
 |
|
 |
|
  J M Hanson, H S Kooistra, J A Mol, E Teske, and B P Meij Plasma profiles of adrenocorticotropic hormone, cortisol, {alpha}-melanocyte-stimulating hormone, and growth hormone in dogs with pituitary-dependent hyperadrenocorticism before and after hypophysectomy. J. Endocrinol., September 1, 2006; 190(3): 601 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mukhina, D. Liu, K. Guo, M. Raccurt, S. Borges-Bendris, H. C. Mertani, and P. E. Lobie Autocrine Growth Hormone Prevents Lactogenic Differentiation of Mouse Mammary Epithelial Cells Endocrinology, April 1, 2006; 147(4): 1819 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dore, I. Lanthier, and J. Sirois Cyclooxygenase-2 Expression in Canine Mammary Tumors Vet. Pathol., March 1, 2003; 40(2): 207 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Szepeshazi, A. V. Schally, P. Armatis, K. Groot, F. Hebert, A. Feil, J. L. Varga, and G. Halmos Antagonists of GHRH Decrease Production of GH and IGF-I in MXT Mouse Mammary Cancers and Inhibit Tumor Growth Endocrinology, October 1, 2001; 142(10): 4371 - 4378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Kaulsay, T. Zhu, W. F. Bennett, K.-O. Lee, and P. E. Lobie The Effects of Autocrine Human Growth Hormone (hGH) on Human Mammary Carcinoma Cell Behavior Are Mediated via the hGH Receptor Endocrinology, February 1, 2001; 142(2): 767 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. van Garderen, H. J. A. van der Poel, J. F. Swennenhuis, E. H. J. Wissink, G. R. Rutteman, E. Hellmén, J. A. Mol, and J. A. Schalken Expression and Molecular Characterization of the Growth Hormone Receptor in Canine Mammary Tissue and Mammary Tumors Endocrinology, December 1, 1999; 140(12): 5907 - 5914. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
